Immunoprecise Antibodies Stock Price History
| IPA Stock | USD 0.42 0.03 6.67% |
Below is the normalized historical share price chart for Immunoprecise Antibodies extending back to July 31, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunoprecise Antibodies stands at 0.42, as last reported on the 23rd of March, with the highest price reaching 0.45 and the lowest price hitting 0.42 during the day.
If you're considering investing in Immunoprecise Stock, it is important to understand the factors that can impact its price. Immunoprecise Antibodies appears to be extremely dangerous, given 3 months investment horizon. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of 0.0456, which attests that the entity had a 0.0456 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Immunoprecise Antibodies, which you can use to evaluate the volatility of the firm. Please utilize Immunoprecise Antibodies' Risk Adjusted Performance of 0.048, downside deviation of 5.82, and Market Risk Adjusted Performance of 0.924 to validate if our risk estimates are consistent with your expectations.
At present, Immunoprecise Antibodies' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 31 M, whereas Other Stockholder Equity is forecasted to decline to about 9.3 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.02, whereas Price To Sales Ratio is forecasted to decline to 0.11. Immunoprecise Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of January 2017 | 200 Day MA 0.6176 | 50 Day MA 0.4492 | Beta 0.39 |
Immunoprecise |
Sharpe Ratio = 0.0456
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IPA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.52 actual daily | 67 67% of assets are less volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Immunoprecise Antibodies is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunoprecise Antibodies by adding it to a well-diversified portfolio.
Price Book 0.8488 | Enterprise Value Ebitda (4.68) | Price Sales 0.8047 | Shares Float 30.5 M | Wall Street Target Price 5 |
Immunoprecise Antibodies Stock Price History Chart
There are several ways to analyze Immunoprecise Stock price data. The simplest method is using a basic Immunoprecise candlestick price chart, which shows Immunoprecise Antibodies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 22, 2025 | 0.64 |
| Lowest Price | February 27, 2025 | 0.33 |
Immunoprecise Antibodies March 23, 2025 Stock Price Synopsis
Various analyses of Immunoprecise Antibodies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immunoprecise Stock. It can be used to describe the percentage change in the price of Immunoprecise Antibodies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immunoprecise Stock.| Immunoprecise Antibodies Price Action Indicator | (0.03) | |
| Immunoprecise Antibodies Price Daily Balance Of Power | (1.00) | |
| Immunoprecise Antibodies Price Rate Of Daily Change | 0.93 |
Immunoprecise Antibodies March 23, 2025 Stock Price Analysis
Immunoprecise Stock Price History Data
The price series of Immunoprecise Antibodies for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 0.31 with a coefficient of variation of 14.98. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.45. The median price for the last 90 days is 0.43. The company completed 1:5 stock split on 23rd of November 2020. Immunoprecise Antibodies completed dividends distribution on 2020-11-23.| Open | High | Low | Close | Volume | ||
03/23/2025 | 0.45 | 0.45 | 0.42 | 0.42 | ||
| 03/21/2025 | 0.45 | 0.45 | 0.42 | 0.42 | 297,665 | |
| 03/20/2025 | 0.44 | 0.46 | 0.40 | 0.45 | 731,159 | |
| 03/19/2025 | 0.42 | 0.44 | 0.41 | 0.44 | 466,418 | |
| 03/18/2025 | 0.42 | 0.43 | 0.39 | 0.41 | 470,881 | |
| 03/17/2025 | 0.39 | 0.44 | 0.38 | 0.43 | 1,464,179 | |
| 03/14/2025 | 0.40 | 0.41 | 0.36 | 0.38 | 1,850,159 | |
| 03/13/2025 | 0.43 | 0.43 | 0.40 | 0.41 | 33,372,579 | |
| 03/12/2025 | 0.38 | 0.38 | 0.35 | 0.36 | 647,629 | |
| 03/11/2025 | 0.37 | 0.41 | 0.37 | 0.40 | 570,017 | |
| 03/10/2025 | 0.38 | 0.39 | 0.35 | 0.38 | 489,853 | |
| 03/07/2025 | 0.40 | 0.41 | 0.37 | 0.39 | 544,934 | |
| 03/06/2025 | 0.40 | 0.41 | 0.35 | 0.40 | 617,564 | |
| 03/05/2025 | 0.35 | 0.40 | 0.33 | 0.39 | 961,495 | |
| 03/04/2025 | 0.31 | 0.35 | 0.27 | 0.35 | 1,421,813 | |
| 03/03/2025 | 0.33 | 0.34 | 0.30 | 0.33 | 845,071 | |
| 02/28/2025 | 0.33 | 0.35 | 0.30 | 0.34 | 761,644 | |
| 02/27/2025 | 0.34 | 0.37 | 0.32 | 0.33 | 1,568,284 | |
| 02/26/2025 | 0.42 | 0.49 | 0.34 | 0.36 | 46,059,806 | |
| 02/25/2025 | 0.39 | 0.40 | 0.33 | 0.37 | 1,017,973 | |
| 02/24/2025 | 0.39 | 0.42 | 0.39 | 0.41 | 422,178 | |
| 02/21/2025 | 0.40 | 0.42 | 0.37 | 0.39 | 850,304 | |
| 02/20/2025 | 0.44 | 0.44 | 0.40 | 0.40 | 513,760 | |
| 02/19/2025 | 0.43 | 0.44 | 0.41 | 0.43 | 391,329 | |
| 02/18/2025 | 0.42 | 0.45 | 0.41 | 0.43 | 518,379 | |
| 02/14/2025 | 0.43 | 0.45 | 0.41 | 0.42 | 1,129,686 | |
| 02/13/2025 | 0.45 | 0.45 | 0.43 | 0.44 | 467,218 | |
| 02/12/2025 | 0.44 | 0.47 | 0.43 | 0.45 | 798,479 | |
| 02/11/2025 | 0.48 | 0.48 | 0.45 | 0.46 | 598,560 | |
| 02/10/2025 | 0.50 | 0.52 | 0.47 | 0.48 | 784,883 | |
| 02/07/2025 | 0.51 | 0.53 | 0.48 | 0.50 | 772,216 | |
| 02/06/2025 | 0.48 | 0.53 | 0.47 | 0.51 | 1,118,091 | |
| 02/05/2025 | 0.45 | 0.50 | 0.45 | 0.47 | 675,568 | |
| 02/04/2025 | 0.47 | 0.50 | 0.44 | 0.47 | 836,543 | |
| 02/03/2025 | 0.43 | 0.47 | 0.43 | 0.44 | 919,781 | |
| 01/31/2025 | 0.47 | 0.50 | 0.46 | 0.47 | 1,042,312 | |
| 01/30/2025 | 0.46 | 0.49 | 0.43 | 0.45 | 1,217,434 | |
| 01/29/2025 | 0.50 | 0.51 | 0.46 | 0.46 | 1,999,455 | |
| 01/28/2025 | 0.52 | 0.54 | 0.48 | 0.52 | 2,183,746 | |
| 01/27/2025 | 0.57 | 0.66 | 0.54 | 0.54 | 4,419,100 | |
| 01/24/2025 | 0.57 | 0.59 | 0.52 | 0.58 | 3,965,537 | |
| 01/23/2025 | 0.60 | 0.61 | 0.53 | 0.60 | 10,836,680 | |
| 01/22/2025 | 0.72 | 0.92 | 0.61 | 0.64 | 328,541,406 | |
| 01/21/2025 | 0.53 | 0.55 | 0.49 | 0.49 | 880,685 | |
| 01/17/2025 | 0.54 | 0.55 | 0.49 | 0.53 | 640,423 | |
| 01/16/2025 | 0.51 | 0.59 | 0.50 | 0.56 | 1,152,067 | |
| 01/15/2025 | 0.45 | 0.54 | 0.44 | 0.52 | 221,034 | |
| 01/14/2025 | 0.52 | 0.52 | 0.43 | 0.46 | 208,177 | |
| 01/13/2025 | 0.52 | 0.55 | 0.51 | 0.52 | 76,657 | |
| 01/10/2025 | 0.56 | 0.58 | 0.51 | 0.53 | 431,535 | |
| 01/08/2025 | 0.53 | 0.55 | 0.51 | 0.54 | 224,711 | |
| 01/07/2025 | 0.52 | 0.58 | 0.48 | 0.54 | 643,152 | |
| 01/06/2025 | 0.54 | 0.55 | 0.48 | 0.55 | 604,632 | |
| 01/03/2025 | 0.46 | 0.54 | 0.45 | 0.52 | 1,255,415 | |
| 01/02/2025 | 0.41 | 0.45 | 0.39 | 0.45 | 285,512 | |
| 12/31/2024 | 0.42 | 0.42 | 0.38 | 0.41 | 322,020 | |
| 12/30/2024 | 0.42 | 0.43 | 0.40 | 0.41 | 235,393 | |
| 12/27/2024 | 0.43 | 0.43 | 0.40 | 0.41 | 488,971 | |
| 12/26/2024 | 0.41 | 0.43 | 0.39 | 0.41 | 167,520 | |
| 12/24/2024 | 0.39 | 0.41 | 0.38 | 0.41 | 123,549 | |
| 12/23/2024 | 0.43 | 0.45 | 0.38 | 0.40 | 638,208 |
About Immunoprecise Antibodies Stock history
Immunoprecise Antibodies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunoprecise is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunoprecise Antibodies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunoprecise Antibodies stock prices may prove useful in developing a viable investing in Immunoprecise Antibodies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.5 M | 31 M | |
| Net Loss | -23.9 M | -22.7 M |
Immunoprecise Antibodies Stock Technical Analysis
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Immunoprecise Antibodies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunoprecise Antibodies' price direction in advance. Along with the technical and fundamental analysis of Immunoprecise Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunoprecise to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.048 | |||
| Jensen Alpha | 0.3366 | |||
| Total Risk Alpha | 0.8693 | |||
| Sortino Ratio | 0.0655 | |||
| Treynor Ratio | 0.914 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |